Your session is about to expire
← Back to Search
tunneled pleural catheter for Congestive Heart Failure (TREAT-CHF Trial)
TREAT-CHF Trial Summary
This trial is studying whether a tunneled pleural catheter (TPC) can improve quality of life for people with congestive heart failure (CHF) who have recurrent symptomatic pleural effusions that are not helped by diuretics.
- Congestive Heart Failure
- Chronic Pleural Effusions
- Shortness of Breath
TREAT-CHF Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TREAT-CHF Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants have been recruited for this trial?
"Affirmative, the information available on clinicaltrials.gov reveals that this research trial is still enrolling patients. Initially published October 1st 2020, it has recently been updated May 18th 2022 and seeks to recruit 210 individuals from a single site."
Is enrollment open for this experiment?
"Per the listings on clinicaltrials.gov, this research study is in a recruitment phase and has been since October 1st 2020. The information was last modified on May 18th 2022."
What are the intended outcomes of this research?
"The primary evaluation metric of this trial across a year-long period will be the amount of hospitalizations and emergency room visits. Secondary outcomes include incidence of pleural procedures, time to pleurodesis among those who achieved it, and classifications according to New york Heath Association's Functional Class (I, II, III or IV)."
Share this study with friends
Copy Link
Messenger